FUNCTION OF C3B AND C3BI RECEPTORS ON U937 CELLS
FUNCTION OF C3B AND C3BI RECEPTORS ON U937 CELLS
批准号:
3462639
负责人:
Ravindra L. Mehta
金额:
$9.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-08-01 至 1991-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project is a detailed analysis of specialized receptors for the
activated third component of complement (C3b receptors) on the surface of
cells of the human macrophage cell line U937. The project owes its
feasibility to a recent advance in our laboratory whereby radiolabeled
C3131I is activated and incorporated as C3b into stable, soluble aggregates
of IgG125I (A-IgG) and IgM125I (A-IgM). More recently, we have used these
probes to study Fc receptors and C3b receptors on U937 cells. We have
demonstrated the presence of C3b receptors on U937 cells and have shown
that C3b receptors alone, do not mediate the endocytosis of ligands
containing C3b. We now propose to extend these studies with the following
specific aims. (1) To determine the function of C3b receptors on U937
cells in the binding and endocytosis of soluble ligands bearing C3b
molecules. (2) To elucidate in a similar fashion the function of C3bi
receptors on U937 cells in the binding of soluble ligands bearing C3bi.
(3) To determine whether the number of C3b and C3bi receptors can be
modulated as is the case for Fc receptors, and if so, whether the modulated
complement receptors gain the ability to mediate endocytosis. We will
utilize fluorochrome labeled monoclonal anti C3b, C3bi, and Fc receptor
antibodies to quantitate the surface expression, density, intracellular
pool and mobility of the C3b, C3bi and Fc receptors on U937 cells, by
fluorescence activated cell sorter (FACS) analysis. The functional
characteristics of these receptors separately and in interaction with each
other would be determined by reacting U937 cells with C3b and C3bi dimers,
AlgM.C3b, AlgM.C3bi, and AlgG.C3bi. The mechanisms of these receptor
interactions would be studied by simultaneous incubation of cells with
soluble ligands and anti receptor antibodies and FACS analysis. These
experiments would be repeated using cells treated with potential modulators
of Fc and C3b and C3bi receptor number and function, and compared with
untreated cells. These studies should reveal important new information
concerning the function of C3b and C3bi receptors and how different types
of receptors can interact with "positive cooperativity." Ultimately this
information may lead to a better understanding of how immune complexes may
escape normal defense mechanisms and deposit in tissues to cause such
diseases as glomerulonephritis, rheumatoid arthritis and vasculitis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE CHANGING PATTERN OF RENAL BIOMARKERS IN CARDIAC CATHERIZATION
-
批准号:8166853
-
项目类别:
-
资助金额:$0.43万
-
财政年份:2009
-
负责人:Ravindra L. Mehta
-
依托单位:
CONTINUOUS URINARY FLOW MEASUREMENT IN ACUTE KIDNEY INJURY
-
批准号:8166868
-
项目类别:
-
资助金额:$0.48万
-
财政年份:2009
-
负责人:Ravindra L. Mehta
-
依托单位:
MARKERS FOR PROGRESSION TO CHRONIC KIDNEY DISEASE - ROLE OF KALLIKREIN
-
批准号:7950970
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2008
-
负责人:Ravindra L. Mehta
-
依托单位:
Resource for Clinical Studies of AKI (Clinical Research/Genomics/Biorepository)
-
批准号:8625439
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2008
-
负责人:Ravindra L. Mehta
-
依托单位:
THE CHANGING PATTERN OF RENAL BIOMARKERS IN CARDIAC CATHERIZATION
-
批准号:7951004
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2008
-
负责人:Ravindra L. Mehta
-
依托单位:
Core A - Resource for Clinical Studies of AKI
-
批准号:10252037
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2008
-
负责人:Ravindra L. Mehta
-
依托单位:
Resource for Clinical Studies of AKI (Clinical Research/Genomics/Biorepository)
-
批准号:9334184
-
项目类别:
-
资助金额:$30.36万
-
财政年份:2008
-
负责人:Ravindra L. Mehta
-
依托单位:
Core A - Resource for Clinical Studies of AKI
-
批准号:10456258
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2008
-
负责人:Ravindra L. Mehta
-
依托单位:
Resource for Clinical Studies of AKI (Clinical Research/Genomics/Biorepository)
-
批准号:8733665
-
项目类别:
-
资助金额:$30.76万
-
财政年份:2008
-
负责人:Ravindra L. Mehta
-
依托单位:
Resource for Clinical Studies of AKI (Clinical Research/Genomics/Biorepository)
-
批准号:8899509
-
项目类别:
-
资助金额:$30.76万
-
财政年份:2008
-
负责人:Ravindra L. Mehta
-
依托单位:
MARKERS FOR PROGRESSION TO CHRONIC KIDNEY DISEASE - ROLE OF KALLIKREIN
-
批准号:7724960
-
项目类别:
-
资助金额:$0.32万
-
财政年份:2007
-
负责人:Ravindra L. Mehta
-
依托单位:
Renal Replacement Therapy Dose in Acute Renal Failure
-
批准号:7045476
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2003
-
负责人:Ravindra L. Mehta
-
依托单位:
CONTINUOUS RENAL REPLACEMENT THERAPY DOSE IN ACUTE RENAL FAILURE
-
批准号:7205643
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2003
-
负责人:Ravindra L. Mehta
-
依托单位:
Clinical Research Enhancement from Supplemental Training
-
批准号:6846411
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2000
-
负责人:Ravindra L. Mehta
-
依托单位:
CLINICAL RESEARCH ENHANCEMENT FROM SUPPLEMENTAL TRAINING
-
批准号:6526759
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2000
-
负责人:Ravindra L. Mehta
-
依托单位:
Clinical Research Enhancement from Supplemental Training
-
批准号:7256326
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2000
-
负责人:Ravindra L. Mehta
-
依托单位:
CLINICAL RESEARCH ENHANCEMENT FROM SUPPLEMENTAL TRAINING
-
批准号:6642107
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2000
-
负责人:Ravindra L. Mehta
-
依托单位:
CLINICAL RESEARCH ENHANCEMENT FROM SUPPLEMENTAL TRAINING
-
批准号:6388592
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2000
-
负责人:Ravindra L. Mehta
-
依托单位:
Clinical Research Enhancement from Supplemental Training
-
批准号:7126829
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2000
-
负责人:Ravindra L. Mehta
-
依托单位:
Clinical Research Enhancement from Supplemental Training
-
批准号:7467312
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2000
-
负责人:Ravindra L. Mehta
-
依托单位:
国内基金
海外基金
Complement C6蛋白抑制DNA损伤修复增敏甲状腺乳头状癌放射性碘治疗的作用及其机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:刘宇佳
-
依托单位: